| Mark Canevari, PHARMD | |
|
2025 Morse Ave, Sacramento, CA 95825-2115 | |
| (916) 973-5362 | |
| Not Available |
| Full Name | Mark Canevari |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2025 Morse Ave, Sacramento, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053886143 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 78884 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark Canevari, PHARMD 8306 Bennett Dr, Stockton, CA 95212-2201 Ph: () - | Mark Canevari, PHARMD 2025 Morse Ave, Sacramento, CA 95825-2115 Ph: (916) 973-5362 |
News Archive
At least one in five people in countries for which data are available were infected with influenza during the first year of the 2009 H1N1 pandemic, according to a new study.
Investigating disparities in the composition of the estrobolome, the gut bacterial genes capable of metabolizing estrogens in both healthy individuals and in women diagnosed with estrogen-driven breast cancer may lead to the development of microbiome-based biomarkers that could help mitigate the risk of certain cancers, according to a review paper published April 22 in the JNCI: Journal of the National Cancer Institute.
King Pharmaceuticals, Inc. and Alpharma Inc. have announced that the two companies have signed a definitive merger agreement under which King will acquire all of the outstanding shares of Class A Common Stock of Alpharma for $37.00 per share in cash for a total equity value of approximately $1.6 billion.
Investigators will begin offering Gleevec(R) (imatinib mesylate)* tablets to patients receiving placebo in a major North American clinical trial after an interim analysis showed participants with Kit-positive gastrointestinal stromal tumors treated with Gleevec following surgery were significantly less likely to experience a return of their cancer compared to those not taking this innovative therapy.
Robotic trained surgeons at Fox Chase Cancer Center in Philadelphia presented a new and novel approach to surgically treat urothelial cancer (in the lining of the bladder or kidney) today at the American Urological Association's Annual Meeting.
› Verified 6 days ago
Dr. Gina Maria Warren, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 Broadway, Coumadin Clinic, Sacramento, CA 95820 Phone: 916-335-8818 | |
Dr. John Sung, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2825 Capitol Ave, Sacramento, CA 95816 Phone: 916-887-0350 | |
Mr. Gerald Lee Freitas I, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8364 Rovana Cir, Sacramento, CA 95828 Phone: 916-379-1657 Fax: 916-379-1691 | |
Michele Ang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3521 Del Paso Rd, Sacramento, CA 95835 Phone: 951-310-0758 | |
Colette Newman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4650 Natomas Blvd, Sacramento, CA 95835 Phone: 916-419-6644 Fax: 916-419-4764 | |
Dr. Anh Minh Phan, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6051 Florin Rd, Sacramento, CA 95823 Phone: 916-427-9731 | |
Dr. Joyce He, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8241 E Stockton Blvd, Pharmacy Administration, Sacramento, CA 95828 Phone: 916-525-6900 |